Transgene's Two Innovative Platforms Progressing Well - Financial Visibility Extended Until End 2023 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 26, 2021) at 10:00 a.m. at the Company's headquarters (400 boulevard
Transgene: Significant Milestones Achieved on All Drug Candidates in 2020 and Financial Visibility until 2022
myvac
TG4001
: expanded randomized Phase II trial to start in HPV-positive anogenital cancers, based on encouraging Phase Ib/II data
BT-001
Invir.IO platform following the partial sale of the stake in Tasly BioPharmaceuticals in 2020
Conference call in English scheduled today at 6:00 p.m. CET Video conference in French on March 10 at 10:00 a.m. CET (details at the end of the release)
Regulatory News:
Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today publishes its financial results for 2020 and provides an update on its product pipeline.
Transgene Appoints Gaëlle Stadtler as Director of Human Resources
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces the appointment of Gaëlle Stadtler as Director of Human Resources. Gaëlle is joining the Executive Committee and will directly report to Hedi Ben Brahim, Chairman and CEO of Transgene.
Commenting on this appointment,
Hedi Ben Brahim said:
Given therapeutic innovation is a globally competitive endeavor, it is critical that Transgene continues to have access to highly skilled and committed employees capable of designing novel immunotherapies that can significantly improve the treatment of solid tumors. In her new role as Director of Human Resources, Gaëlle Stadtler s mission is to continue developing the skills of our 150 employees, to attract and retain talent and to support an innovative corporate culture that is central to our success.